CellaVision AB (publ) (CEVI.ST)

SEK 222.0

(2.07%)

Operating Income Summary of CellaVision AB (publ)

  • CellaVision AB (publ)'s latest annual operating income in 2023 was 167.05 Million SEK , up 5.55% from previous year.
  • CellaVision AB (publ)'s latest quarterly operating income in 2024 Q1 was 38.81 Million SEK , down -37.94% from previous quarter.
  • CellaVision AB (publ) reported an annual operating income of 158.26 Million SEK in 2022, down -2.74% from previous year.
  • CellaVision AB (publ) reported an annual operating income of 162.73 Million SEK in 2021, up 47.57% from previous year.
  • CellaVision AB (publ) reported a quarterly operating income of 38.81 Million SEK for 2024 Q1, down -37.94% from previous quarter.
  • CellaVision AB (publ) reported a quarterly operating income of 38.39 Million SEK for 2024 Q3, down -21.82% from previous quarter.

Annual Operating Income Chart of CellaVision AB (publ) (2023 - 2007)

Historical Annual Operating Income of CellaVision AB (publ) (2023 - 2007)

Year Operating Income Operating Income Growth
2023 167.05 Million SEK 5.55%
2022 158.26 Million SEK -2.74%
2021 162.73 Million SEK 47.57%
2020 110.27 Million SEK -12.88%
2019 126.57 Million SEK 13.41%
2018 111.6 Million SEK 22.79%
2017 90.89 Million SEK 22.55%
2016 74.16 Million SEK 13.29%
2015 65.47 Million SEK 52.92%
2014 42.81 Million SEK 65.01%
2013 25.94 Million SEK 25.33%
2012 20.7 Million SEK 16.3%
2011 17.8 Million SEK 27.62%
2010 13.94 Million SEK -5.61%
2009 14.77 Million SEK 10.41%
2008 13.38 Million SEK 325.97%
2007 3.14 Million SEK 0.0%

Peer Operating Income Comparison of CellaVision AB (publ)

Name Operating Income Operating Income Difference
Acarix AB (publ) -77.55 Million SEK 315.402%
ADDvise Group AB (publ) 300.6 Million SEK 44.427%
ADDvise Group AB (publ) 300.6 Million SEK 44.427%
Arcoma AB 4.66 Million SEK -3484.785%
Bactiguard Holding AB (publ) -131.93 Million SEK 226.618%
BICO Group AB (publ) -618.3 Million SEK 127.018%
Boule Diagnostics AB (publ) 39.27 Million SEK -325.391%
Clinical Laserthermia Systems AB (publ) -65.93 Million SEK 353.365%
Chordate Medical Holding AB (publ) -29.57 Million SEK 664.904%
C-Rad AB (publ) 44.24 Million SEK -277.568%
Duearity AB (publ) -25.76 Million SEK 748.414%
Dignitana AB (publ) -15.02 Million SEK 1211.746%
Episurf Medical AB (publ) -94.8 Million SEK 276.214%
Getinge AB (publ) 3.81 Billion SEK 95.62%
Scandinavian Real Heart AB (Publ) -68.44 Million SEK 344.063%
Iconovo AB (publ) -45.77 Million SEK 464.925%
Integrum AB (publ) 6.51 Million SEK -2465.146%
Luxbright AB (publ) -25.8 Million SEK 747.373%
Mentice AB (publ) -679 Thousand SEK 24702.504%
OssDsign AB (publ) -91.95 Million SEK 281.664%
Paxman AB (publ) 12.61 Million SEK -1223.805%
Promimic AB (publ) -9.11 Million SEK 1932.101%
Qlife Holding AB (publ) -168.69 Million SEK 199.024%
SciBase Holding AB (publ) -53.93 Million SEK 409.704%
ScandiDos AB (publ) -13.48 Million SEK 1338.975%
Sectra AB (publ) 518.49 Million SEK 67.781%
Sedana Medical AB (publ) -65.54 Million SEK 354.857%
Senzime AB (publ) -133.74 Million SEK 224.903%
SpectraCure AB (publ) -21.35 Million SEK 882.404%
Stille AB 44.95 Million SEK -271.621%
Vitrolife AB (publ) -3.58 Billion SEK 104.655%
Xvivo Perfusion AB (publ) 38.5 Million SEK -333.831%